Drug Delivery Technology Investing - Cure Pharmaceutical- w/Rob Davidson
Listen now
Description
Listen to Rob, CEO, and previous CEO multiple times plus corporate board member for several companies in the industry, discuss this niche in the pharma world. A publicly traded company, focusing on the delivery system of medications, w/systems offering less toxicology and fewer side effects. W/a proprietary system they offer a delivery system that is unique and is not processed thru the stomach. Many investors should find this interview and company to be very interesting.
More Episodes
Listen to Todd, founder and owner of Zinc Income Fund, a specialty lender in the residential rehab and resale business. These securitized loans are of less than 2 years duration, and pay Zinc's investors monthly payouts. In a day of record low interest rates this strategy has a strong track...
Published 11/16/21
Published 11/16/21
Until now, investors could invest into publicly traded companies that are listed on the exchanges (NY Stock Exchange, NASDAQ, etc.), with all information re: these companies being made available to the public via quarterly earnings announcements and audited financial reports. But, the vast...
Published 07/23/21
Links
Genres
Artwork or description wrong?
Request an update »
Updates may take a few minutes.
Do you host a podcast?
Track your ranks and reviews from Spotify, Apple Podcasts and more.
See hourly chart positions and more than 30 days of history.
Get Chartable Analytics »
See hourly chart positions and more than 30 days of history.
